

Shares of Grail, the pioneer in multi-cancer early detection (MCED) technology, experienced a significant market rally on Monday, climbing 33%…

In a landmark development for the rare disease community, the U.S. Food and Drug Administration (FDA) granted approval on Friday…

In a move that has reignited global tensions over the future of the ocean floor, a California-based startup has applied…